These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor. Bussiere R; Lacampagne A; Reiken S; Liu X; Scheuerman V; Zalk R; Martin C; Checler F; Marks AR; Chami M J Biol Chem; 2017 Jun; 292(24):10153-10168. PubMed ID: 28476886 [TBL] [Abstract][Full Text] [Related]
9. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Kitazawa M; Green KN; Caccamo A; LaFerla FM Am J Pathol; 2006 Jun; 168(6):1986-97. PubMed ID: 16723713 [TBL] [Abstract][Full Text] [Related]
10. Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors. Robinson K; Culley D; Waring S; Lamb GD; Easton C; Casarotto MG; Dulhunty AF Life Sci; 2020 Nov; 260():118234. PubMed ID: 32791148 [TBL] [Abstract][Full Text] [Related]
11. Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis. Jayaraman M; Kannayiram G; Rajadas J Arch Biochem Biophys; 2008 Jun; 474(1):15-21. PubMed ID: 18397759 [TBL] [Abstract][Full Text] [Related]
12. Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model. Kitazawa M; Vasilevko V; Cribbs DH; LaFerla FM J Neurosci; 2009 May; 29(19):6132-41. PubMed ID: 19439591 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. Sugarman MC; Kitazawa M; Baker M; Caiozzo VJ; Querfurth HW; LaFerla FM Neurobiol Aging; 2006 Mar; 27(3):423-32. PubMed ID: 15950323 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202 [TBL] [Abstract][Full Text] [Related]
16. Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle. Ahern GP; Junankar PR; Pace SM; Curtis S; Mould JA; Dulhunty AF J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):313-26. PubMed ID: 9852316 [TBL] [Abstract][Full Text] [Related]
19. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle. Treves S; Scutari E; Robert M; Groh S; Ottolia M; Prestipino G; Ronjat M; Zorzato F Biochemistry; 1997 Sep; 36(38):11496-503. PubMed ID: 9298970 [TBL] [Abstract][Full Text] [Related]
20. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Sugarman MC; Yamasaki TR; Oddo S; Echegoyen JC; Murphy MP; Golde TE; Jannatipour M; Leissring MA; LaFerla FM Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6334-9. PubMed ID: 11972038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]